Success Metrics

Clinical Success Rate

100.0%

Based on 4 completed trials

Completion Rate

100%(4/4)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

100%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

N/ANon-phased studies

4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(4)

Detailed Status

Completed4

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

completed4100%

Recent Activity

0 active trials

Showing 4 of 4

completednot_applicable

Pilot evaluatIon Of NovEl tEmpoRary ExtraVascular PACING (PIONEER EV PACING) Study

NCT05610033

completednot_applicable

Clinical Trials (4)

Showing 4 of 4 trials

NCT05610033Not Applicable

Pilot evaluatIon Of NovEl tEmpoRary ExtraVascular PACING (PIONEER EV PACING) Study

Completed

NCT05633394Not Applicable

Subcostal Temporary Extravascular Pacing V Study

Completed

NCT05457673Not Applicable

Subcostal Temporary Extravascular Pacing IV (STEP IV) Study

Completed

NCT04538287Not Applicable

AtaCor Subcostal Temporary Extravascular Pacing III Study

Completed

All 4 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 4